Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Fuan Pharmaceutical Group Co Ltd

+ Add to Watchlist

300194:CH

22.530 CNY 0.620 2.83%

As of 02:00:28 ET on 03/04/2015.

Snapshot for Fuan Pharmaceutical Group Co Ltd (300194)

Open: 22.000 Day's Range: 21.900 - 22.600 Volume: 4,173,217
Previous Close: 21.910 52wk Range: 16.000 - 26.970 1-Yr Rtn: +25.94%

Stock Chart for 300194

No chart data available.
  • 300194:CH 22.530
  • 1D
  • 1M
  • 1Y
21.910
Interactive 300194 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300194

Current P/E Ratio (ttm) 153.6136
Estimated P/E(12/2014) 80.4643
Relative P/E vs. SZ399006 2.0210
Earnings Per Share (CNY) (ttm) 0.1467
Est. EPS (CNY) (12/2014) 0.2800
Est. PEG Ratio -
Market Cap (M CNY) 5,860.73
Shares Outstanding (M) 260.13
30 Day Average Volume 1,451,842
Price/Book (mrq) 3.4390
Price/Sale (ttm) 16.4324
Dividend Indicated Gross Yield 0.59%
Cash Dividend (CNY) 0.1333
Dividend Ex-Date 05/13/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300194

No data available

Company Profile & Key Executives for 300194

Fuan Pharmaceutical Group Co., Ltd. develops, produces and sells Monocyclic -lactams, penicillins and cephalosporins bulk drugs and formulations. The Company's main products are aztreonam bulk drugs and formulations, ticarcillin sodium, sulbenicillin disodium bulk drugs and formulations, cefathiamidine and ceftizoxime sodium formulations.

Wang TianxiangChairmanJiang ChenPresident
Huang TaoVice PresidentZhou XudongVice President
More Company Profile & Key Executives for 300194

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil